Clinical reports were first published in large cohorts in the Netherlands, with the phospholamban R14del mutation identified in up to 15% of patients diagnosed with ARVC or DCM [2]. The gene discussed is PLN; the disease is arrhythmogenic right ventricular cardiomyopathy.